The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concurrent chemoradiotherapy with S-1 plus cisplatin for advanced cervical esophageal carcinoma: Long-term results of a phase II trial.
Hiroaki Iwase
No relevant relationships to disclose
Masaaki Shimada
No relevant relationships to disclose
Tomoyuki Tsuzuki
No relevant relationships to disclose
Noboru Hirashima
No relevant relationships to disclose
Masayuki Okeya
No relevant relationships to disclose
Nobumitsu Ryuge
No relevant relationships to disclose
Yuichi Kida
No relevant relationships to disclose
Takeshi Kuno
No relevant relationships to disclose
Yusaku Tanaka
No relevant relationships to disclose
Eriko Kato
No relevant relationships to disclose